Table 1  Histopathology    FISH   CGH imbalances
Lab No   Sex/Age   Type   Grade   Stage   Other    Losses   Gains
Benign
747–98  M/65  Ch. inflammation
738–98  F/53  Ch. inflammation
162–99  M/70  Ch. Inflammation Moderate dysplasia
548–98  M/51  Granuloma    CBO
352–99  F/55  Granuloma    CBO  Xc 3, AR 1
286–98  M/45  Granuloma with inflammatory polyp     9c 1, 17c 2  9p, 16p, 22q
Malignant
453–99  F/49  SCC  G1  ?  CBO  topo 1
2228–99  F/60  SCC  G1   CBO  9c 1, 17c 3, Xc 3  1 cen-p31, 3p,9pter-q13  19p
229–99  M/70  SCC  G2  T3  KCs  Xc 2, 17c 2
210–99  M/70  SCC  G3  T3  KCs
471–99  M/60  SCC  G3  ?  CBO+SM  Xc 2, 17c 3
217–98  F/51  SCC  G3  T3  CBO   9p
476–98  M/53  SCC  G3  T3  CBO  9c 2, 17c 3  1p21-p22, 2q13-q21, 8p, 13q, 18q  19p
479–98  M/47  SCC  G2–3   CBO   2q13-q21, 8p  19p
345–98  M/61  TCC  G1  ?  CBO+SM
240–98  F/55  TCC  G2  ?   Xc 1, 9c 2,17c 2
746–98  F/60  TCC  G2    Xc 2–3, 9c2–3, 17c 2–6(4)
4540–98  M/62  TCC  G2  ?
5605–97  M/50  TCC  G3  T3  SM  Xc 2, AR 3–5  8p21-pter
5653–98  F/50  TCC  G3  T3   Xc 1–3, 9c 2, 17c 2  1 cen-p31  5p, 17q, 20q
SCC, squamous cell carcinoma; TCC, transitional cell carcin oma; G1, well differentiated; G2, moderately differentiated; G3, poorly differ entiated; CBO, calcified bilharzial ova; I K:Cs, keratinzed cells; SM, squamous metapla